Lista de obras - Da-Liang Ou - Dominio Público Uruguay

CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia.

artículo científico publicado en 2010

Cytarabine-Resistant -ITD Leukemia Cells are Associated with Mutation and Multiple Pathway Alterations-Possible Therapeutic Efficacy of Cabozantinib ⬇️

artículo científico

Deciphering the Role of Pyrvinium Pamoate in the Generation of Integrated Stress Response and Modulation of Mitochondrial Function in Myeloid Leukemia Cells through Transcriptome Analysis

artículo científico publicado en 2021

Development of a PD-L1-Expressing Orthotopic Liver Cancer Model: Implications for Immunotherapy for Hepatocellular Carcinoma

scientific article published on 22 June 2018

H3K9 histone methyltransferase, KMT1E/SETDB1, cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis

artículo científico publicado en 2014

Immunomodulatory Effects of Current Targeted Therapies on Hepatocellular Carcinoma: Implication for the Future of Immunotherapy

artículo científico publicado en 2018

Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma

artículo científico publicado en 2009

Induction of DNA damage-inducible gene GADD45beta contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells

artículo científico publicado en 2010

IκB kinases increase Myc protein stability and enhance progression of breast cancer cells ⬇️

artículo científico publicado en 2011

KRAS mutation is a predictor of oxaliplatin sensitivity in colon cancer cells

artículo científico publicado en 2012

Mouse Models for Immunotherapy in Hepatocellular Carcinoma

scientific article published on 15 November 2019

Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer

artículo científico publicado en 2022

Potentiating the efficacy of molecular targeted therapy for hepatocellular carcinoma by inhibiting the insulin-like growth factor pathway

artículo científico publicado en 2013

TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma

artículo científico publicado en 2019

Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin